Journal article 539 views
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness
Beth S. Woods,
Eleftherios Sideris,
Matthew R. Sydes,
Melissa R. Gannon,
Mahesh K.B. Parmar,
Mymoona Alzouebi,
Gerhardt Attard,
Alison J. Birtle,
Susannah Brock,
Richard Cathomas,
Prabir R. Chakraborti,
Audrey Cook,
William R. Cross,
David P. Dearnaley,
Joanna Gale,
Stephanie Gibbs,
John D. Graham,
Robert Hughes,
Rob J. Jones,
Robert Laing,
Malcolm D. Mason,
David Matheson,
Duncan B. McLaren,
Robin Millman,
Joe M. O'Sullivan,
Omi Parikh,
Christopher C. Parker,
Clive Peedell,
Andrew Protheroe,
Alastair W.S. Ritchie,
Angus Robinson,
J. Martin Russell,
Matthew S. Simms,
Narayanan N. Srihari,
Rajaguru Srinivasan,
John N. Staffurth,
Santhanam Sundar,
George N. Thalmann,
Shaun Tolan,
Anna T.H. Tran,
David Tsang,
John Wagstaff,
Nicholas D. James,
Mark J. Sculpher
European Urology Oncology, Volume: 1, Issue: 6, Pages: 449 - 458
Swansea University Author: John Wagstaff
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1016/j.euo.2018.06.004
Abstract
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness
| Published in: | European Urology Oncology |
|---|---|
| ISSN: | 25889311 |
| Published: |
2018
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa47923 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| College: |
Faculty of Medicine, Health and Life Sciences |
|---|---|
| Issue: |
6 |
| Start Page: |
449 |
| End Page: |
458 |